SCHEMBL752807

SCHEMBL752807

Cc1ccccccsc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.45
TSHR P16473 2/20 0.45
LMNA P02545 1/20 0.36
ALOX12 P18054 1/20 0.36
ALDH1A1 P00352 5/20 0.36
PKM P14618 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
RAB9A P51151 4/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
HSD17B10 Q99714 2/20 0.35
KDM4E B2RXH2 2/20 0.35
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
ALOX15 P16050 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CTNNB1 P35222 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4369366 0.97 ACHE (0.43) ACHETSHRLMNAALOX12ALDH1A1
SCHEMBL753567 0.85 TSHR (0.41) ACHETSHRLMNAALOX12ALDH1A1
Propionic Acid SCHEMBL28888514 0.84 CTNNB1 (0.41) TSHRLMNAALDH1A1PKMRAB9A
Hydrochloric Acid SCHEMBL4373437 0.83 TSHR (0.39) ACHETSHRLMNAALOX12ALDH1A1
Water SCHEMBL28584406 0.83 TSHR (0.39) ACHETSHRLMNAALOX12ALDH1A1
SCHEMBL752673 0.80 TSHR (0.41) ACHETSHRALOX12ALDH1A1PKM
Hydrochloric Acid SCHEMBL154108 0.78 TSHR (0.39) ACHETSHRALOX12ALDH1A1PKM
Water SCHEMBL5196978 0.78 TSHR (0.39) ACHETSHRALOX12ALDH1A1PKM
Hydrochloric Acid SCHEMBL31150435 0.78 TSHR (0.39) ACHETSHRALOX12ALDH1A1PKM
SCHEMBL113923 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046767-B1 PROCESS FOR PREPARING DIAMINOPHENOTHIAZINIUM COMPOUNDS PROVENCE TECHNOLOGIES (FR) 2015-04-22 EP claimed
EP-2128269-B1 Light emission modifiers and their uses in nucleic acid detection, amplification and analysis ROCHE DIAGNOSTICS GMBH (DE) 2011-04-27 EP claimed
EP-2046767-A2 PROCESS FOR PREPARING DIAMINOPHENOTHIAZINIUM COMPOUNDS Provence Technologies (FR) 2009-04-15 EP claimed
WO-2008006979-A2 PROCESS FOR PREPARING DIAMINOPHENOTHIAZINIUM COMPOUNDS PROVENCE TECHNOLOGIES (FR) 2008-01-17 WO claimed
EP-0094398-B1 DYESTUFF COMPOSITION FOR HISTOLOGICAL EXAMINATIONS REANAL FINOMVEGYSZERGYAR (HU) 1986-10-29 EP claimed
US-4595582-A Dyestuff composition for histological examinations REANAL FINOMVEGYSZERGYAR (HU) 1986-06-17 US claimed
EP-0094398-A4 DYESTUFF COMPOSITION FOR HISTOLOGICAL EXAMINATIONS. REANAL FINOMVEGYSZERGYAR (HU) 1984-04-06 EP claimed
EP-0094398-A1 DYESTUFF COMPOSITION FOR HISTOLOGICAL EXAMINATIONS. REANAL FINOMVEGYSZERGYAR (HU) 1983-11-23 EP claimed
WO-1983001779-A1 DYESTUFF COMPOSITION FOR HISTOLOGICAL EXAMINATIONS BALOGH, György 1983-05-26 WO claimed
US-12590871-B2 Methods and systems for preparing and analyzing cellular samples for morphological characteristics and biomarker expression VENTANA MEDICAL SYSTEMS, INC. (US) 2026-03-31 US disclosed
WO-2025131829-A1 METHOD AND SYSTEM FOR APPLYING A LIQUID SAMPLE ONTO A SUBSTRATE FOR IMAGE ANALYSIS F. HOFFMANN-LA ROCHE AG (CH) 2025-06-26 WO disclosed
EP-3559122-B1 SYNTHESIS OF A THIOSULFONIC ACID BY A STEP OF PERIODATE MEDIATED OXIDATIVE COUPLING OF A THIOSULFONIC ACID WITH AN ANILINE WISTA LAB LTD (SG) 2025-01-22 EP disclosed
CN-115605254-A Balloon catheter with precise drug elution capability 巴德股份有限公司(US) 2023-01-13 CN disclosed
CN-115052869-A Substituted thiophenecarboxamides and derivatives thereof 拜耳公司 2022-09-13 CN disclosed
EP-0094398-A4 DYESTUFF COMPOSITION FOR HISTOLOGICAL EXAMINATIONS. REANAL FINOMVEGYSZERGYAR (HU) 1984-04-06 EP disclosed
EP-0094398-A4 DYESTUFF COMPOSITION FOR HISTOLOGICAL EXAMINATIONS. REANAL FINOMVEGYSZERGYAR (HU) 1984-04-06 EP disclosed
EP-0094398-A1 DYESTUFF COMPOSITION FOR HISTOLOGICAL EXAMINATIONS. REANAL FINOMVEGYSZERGYAR (HU) 1983-11-23 EP disclosed
EP-0094398-A1 DYESTUFF COMPOSITION FOR HISTOLOGICAL EXAMINATIONS. REANAL FINOMVEGYSZERGYAR (HU) 1983-11-23 EP disclosed
WO-1983001779-A1 DYESTUFF COMPOSITION FOR HISTOLOGICAL EXAMINATIONS BALOGH, György 1983-05-26 WO disclosed
WO-1983001779-A1 DYESTUFF COMPOSITION FOR HISTOLOGICAL EXAMINATIONS BALOGH, György 1983-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590871-B2 Methods and systems for preparing and analyzing cellular samples for morphological characteristics and biomarker expression CD63, MKI67, CD68 ACHE 4678/4885TSHR 1475/4885LMNA 1221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.